trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'rectal', 'destiny,crc,02', 'colorectal']
#asco2023: #destiny-crc02 results from #colorectal #cancer 5.4 vs. 6.4 mg/kg resulting in rr = 37.8 vs. 27.5. therefore, the recommended dose will be 5.4 mg/kg. #cancerresearch #her-2 
Co-Director/Co-Leader GI Oncology Research; Director, Young Adult Cancers Program; Co-Chair, NCI GI Steering Committee; and Director for Strategic Relations